Yes, if breakpoints are known for translocations, it is possible to design a custom panel, combine it with the genome-wide CNV panel and analyze the data using the Tapestri Genome Editing pipeline.
Please note that translocation breakpoint sequences must be known at the panel design stage, so amplicons can be appropriately designed to capture these events. De novo translocations cannot be detected. To move forward with a translocation panel design, please contact support@missionbio.com